Tilray Brands, Inc. Gain (Loss) on Derivative Instruments, Net, Pretax
Tilray Brands, Inc. (TLRY) reported Gain (Loss) on Derivative Instruments, Net, Pretax of -$3.50 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2026-07-28
- Tilray Brands, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2026-05-31 was $0.00.
- Tilray Brands, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2026-02-28 was $0.00, a 100.00% decline year-over-year.
- Tilray Brands, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2025-11-30 was $175.00K, a 79.70% decline year-over-year.
- Tilray Brands, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2025-08-31 was -$3.67M, a 627.30% decline year-over-year.
- Tilray Brands, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2026 was -$3.50M, a 261.73% decline from fiscal 2025.
- Tilray Brands, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2025 was $2.16M.
- Tilray Brands, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2024 was -$21.17M.
- Tilray Brands, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2023 was -$27.36M, a 111.76% decline from fiscal 2022.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $0.00 derived: sum of 2 quarters · filed 2026-07-28 | $175.00K derived: sum of 3 quarters · filed 2026-07-28 | -$3.50M 10-K · filed 2026-07-28 | |
| 2026-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $175.00K derived: sum of 2 quarters · filed 2026-04-01 | -$3.50M 10-Q · filed 2026-04-01 | -$4.23M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-11-30 | $175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | -$3.50M 10-Q · filed 2026-01-08 | -$4.23M derived: sum of 3 quarters · filed 2026-07-28 | -$2.89M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-08-31 | -$3.67M 10-Q · filed 2025-10-09 | -$4.41M derived: sum of 2 quarters · filed 2026-07-28 | -$3.07M derived: sum of 3 quarters · filed 2026-07-28 | -$2.21M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-05-31 | -$735.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $603.00K derived: sum of 2 quarters · filed 2026-07-28 | $1.47M derived: sum of 3 quarters · filed 2026-07-28 | $2.16M 10-K · filed 2026-07-28 | |
| 2025-02-28 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $2.20M derived: sum of 2 quarters · filed 2026-04-01 | $2.90M 10-Q · filed 2026-04-01 | -$4.56M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2024-11-30 | $862.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $1.56M 10-Q · filed 2026-01-08 | -$5.90M derived: sum of 3 quarters · filed 2026-07-28 | -$11.62M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2024-08-31 | $696.00K 10-Q · filed 2025-10-09 | -$6.76M derived: sum of 2 quarters · filed 2026-07-28 | -$12.48M derived: sum of 3 quarters · filed 2026-07-28 | -$10.13M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2024-05-31 | -$7.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | -$13.18M derived: sum of 2 quarters · filed 2026-07-28 | -$10.83M derived: sum of 3 quarters · filed 2026-07-28 | -$21.17M 10-K · filed 2026-07-28 | |
| 2024-02-29 | -$5.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08 | -$3.37M derived: sum of 2 quarters · filed 2025-04-08 | -$13.72M 10-Q · filed 2025-04-08 | -$27.55M derived: sum of 4 quarters · filed 2025-07-29 | |
| 2023-11-30 | $2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10 | -$7.99M 10-Q · filed 2025-01-10 | -$21.82M derived: sum of 3 quarters · filed 2025-07-29 | -$16.36M derived: sum of 4 quarters · filed 2025-07-29 | |
| 2023-08-31 | -$10.35M 10-Q · filed 2024-10-10 | -$24.18M derived: sum of 2 quarters · filed 2025-07-29 | -$18.71M derived: sum of 3 quarters · filed 2025-07-29 | -$31.37M derived: sum of 4 quarters · filed 2025-07-29 | |
| 2023-05-31 | -$13.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | -$8.37M derived: sum of 2 quarters · filed 2025-07-29 | -$21.03M derived: sum of 3 quarters · filed 2025-07-29 | -$27.36M 10-K · filed 2025-07-29 | -$31.21M 10-K · filed 2023-07-26 |
| 2023-02-28 | $5.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | -$7.20M derived: sum of 2 quarters · filed 2024-04-09 | -$13.53M 10-Q · filed 2024-04-09 | $8.44M derived: sum of 4 quarters · filed 2024-10-10 | |
| 2022-11-30 | -$12.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | -$19.00M 10-Q · filed 2024-01-09 | $2.98M derived: sum of 3 quarters · filed 2024-10-10 | $80.19M derived: sum of 4 quarters · filed 2024-10-10 | |
| 2022-08-31 | -$6.34M 10-Q · filed 2024-10-10 | $15.64M derived: sum of 2 quarters · filed 2024-10-10 | $92.85M derived: sum of 3 quarters · filed 2024-10-10 | $168.58M derived: sum of 4 quarters · filed 2024-10-10 | |
| 2022-05-31 | $21.97M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $99.19M derived: sum of 2 quarters · filed 2024-07-30 | $174.91M derived: sum of 3 quarters · filed 2024-07-30 | $232.63M 10-K · filed 2024-07-30 | $227.58M 10-K · filed 2022-07-28 |
| 2022-02-28 | $77.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | $152.94M derived: sum of 2 quarters · filed 2023-04-10 | $210.65M 10-Q · filed 2023-04-10 | $324.99M derived: sum of 4 quarters · filed 2023-07-26 | |
| 2021-11-30 | $75.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $133.44M 10-Q · filed 2023-01-09 | $247.78M derived: sum of 3 quarters · filed 2023-07-26 | ||
| 2021-08-31 | $57.71M 10-Q · filed 2022-10-07 | $172.05M derived: sum of 2 quarters · filed 2023-07-26 | |||
| 2021-05-31 | $114.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | -$169.54M 10-K · filed 2023-07-26 | |||
| 2021-03-31 | $134.00K 10-Q · filed 2021-05-10 | ||||
| 2021-02-28 | -$213.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06 | -$283.88M 10-Q · filed 2022-04-06 | |||
| 2020-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $257.00K derived: sum of 2 quarters · filed 2021-02-19 | $381.00K derived: sum of 3 quarters · filed 2021-02-19 | $425.00K 10-K · filed 2021-02-19 | |
| 2020-11-30 | -$70.34M 10-Q · filed 2022-01-10 | ||||
| 2020-09-30 | $127.00K 10-Q · filed 2020-11-09 | $251.00K derived: sum of 2 quarters · filed 2020-11-09 | $295.00K 10-Q · filed 2020-11-09 | ||
| 2020-06-30 | $124.00K 10-Q · filed 2020-08-10 | $167.00K 10-Q · filed 2020-08-10 | |||
| 2020-05-31 | $53.61M 10-K · filed 2022-07-28 | ||||
| 2020-03-31 | $44.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |